vs
COMPASS MINERALS INTERNATIONAL INC（CMP）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是COMPASS MINERALS INTERNATIONAL INC的1.6倍（$622.0M vs $396.1M），Royalty Pharma plc净利率更高（34.4% vs 4.7%，领先29.7%），COMPASS MINERALS INTERNATIONAL INC同比增速更快（28.9% vs 4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 4.3%）
指南针矿产国际是一家美国上市矿产企业，总部位于堪萨斯州欧弗兰帕克，是盐、氯化镁和硫酸钾等产品的领先生产商。公司面向北美和英国客户供应经处理与未经处理的散装道路除冰盐，同时向全球种植者提供植物营养产品，此外也生产民用除冰、水质调节产品及相关商用产品。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CMP vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.6倍
$396.1M
营收增速更快
CMP
高出24.2%
4.8%
净利率更高
RPRX
高出29.7%
4.7%
两年增速更快
RPRX
近两年复合增速
4.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $396.1M | $622.0M |
| 净利润 | $18.6M | $214.2M |
| 毛利率 | 16.0% | — |
| 营业利润率 | 9.2% | 62.4% |
| 净利率 | 4.7% | 34.4% |
| 营收同比 | 28.9% | 4.8% |
| 净利润同比 | 178.8% | 2.9% |
| 每股收益（稀释后） | $0.43 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CMPRPRX
| Q4 25 | $396.1M | $622.0M | ||
| Q3 25 | $227.5M | $609.3M | ||
| Q2 25 | $214.6M | $578.7M | ||
| Q1 25 | $494.6M | $568.2M | ||
| Q4 24 | $307.2M | $593.6M | ||
| Q3 24 | $208.8M | $564.7M | ||
| Q2 24 | $202.9M | $537.3M | ||
| Q1 24 | $364.0M | $568.0M |
净利润CMPRPRX
| Q4 25 | $18.6M | $214.2M | ||
| Q3 25 | $-7.2M | $288.2M | ||
| Q2 25 | $-17.0M | $30.2M | ||
| Q1 25 | $-32.0M | $238.3M | ||
| Q4 24 | $-23.6M | $208.2M | ||
| Q3 24 | $-48.3M | $544.0M | ||
| Q2 24 | $-43.6M | $102.0M | ||
| Q1 24 | $-38.9M | $4.8M |
毛利率CMPRPRX
| Q4 25 | 16.0% | — | ||
| Q3 25 | 16.9% | — | ||
| Q2 25 | 19.2% | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 9.3% | — | ||
| Q2 24 | 16.1% | — | ||
| Q1 24 | 19.7% | — |
营业利润率CMPRPRX
| Q4 25 | 9.2% | 62.4% | ||
| Q3 25 | 5.3% | 70.1% | ||
| Q2 25 | 7.4% | 36.3% | ||
| Q1 25 | -0.6% | 94.0% | ||
| Q4 24 | 0.2% | 60.9% | ||
| Q3 24 | -14.3% | — | ||
| Q2 24 | 2.9% | 50.2% | ||
| Q1 24 | -10.8% | -13.0% |
净利率CMPRPRX
| Q4 25 | 4.7% | 34.4% | ||
| Q3 25 | -3.2% | 47.3% | ||
| Q2 25 | -7.9% | 5.2% | ||
| Q1 25 | -6.5% | 41.9% | ||
| Q4 24 | -7.7% | 35.1% | ||
| Q3 24 | -23.1% | 96.3% | ||
| Q2 24 | -21.5% | 19.0% | ||
| Q1 24 | -10.7% | 0.8% |
每股收益（稀释后）CMPRPRX
| Q4 25 | $0.43 | $0.49 | ||
| Q3 25 | — | $0.67 | ||
| Q2 25 | $-0.41 | $0.07 | ||
| Q1 25 | $-0.77 | $0.55 | ||
| Q4 24 | $-0.57 | $0.46 | ||
| Q3 24 | $-1.17 | $1.21 | ||
| Q2 24 | $-1.05 | $0.23 | ||
| Q1 24 | $-0.94 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $46.7M | $618.7M |
| 总债务越低越好 | $890.0M | $9.0B |
| 股东权益账面价值 | $260.5M | $9.7B |
| 总资产 | $1.5B | $19.6B |
| 负债/权益比越低杠杆越低 | 3.42× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CMPRPRX
| Q4 25 | $46.7M | $618.7M | ||
| Q3 25 | $59.7M | $938.9M | ||
| Q2 25 | $79.4M | $631.9M | ||
| Q1 25 | $49.5M | $1.1B | ||
| Q4 24 | $45.8M | $929.0M | ||
| Q3 24 | $20.2M | $950.1M | ||
| Q2 24 | $12.8M | $1.8B | ||
| Q1 24 | $38.3M | $843.0M |
总债务CMPRPRX
| Q4 25 | $890.0M | $9.0B | ||
| Q3 25 | $839.8M | $8.9B | ||
| Q2 25 | $833.4M | $8.0B | ||
| Q1 25 | $807.6M | $7.6B | ||
| Q4 24 | $974.4M | $7.6B | ||
| Q3 24 | $921.2M | $7.6B | ||
| Q2 24 | $875.1M | $7.6B | ||
| Q1 24 | $877.2M | $6.1B |
股东权益CMPRPRX
| Q4 25 | $260.5M | $9.7B | ||
| Q3 25 | $234.1M | $9.6B | ||
| Q2 25 | $249.8M | $9.5B | ||
| Q1 25 | $236.5M | $9.8B | ||
| Q4 24 | $263.0M | $10.3B | ||
| Q3 24 | $316.6M | $10.3B | ||
| Q2 24 | $352.1M | $9.8B | ||
| Q1 24 | $400.4M | $9.9B |
总资产CMPRPRX
| Q4 25 | $1.5B | $19.6B | ||
| Q3 25 | $1.5B | $19.3B | ||
| Q2 25 | $1.5B | $18.3B | ||
| Q1 25 | $1.5B | $17.6B | ||
| Q4 24 | $1.7B | $18.2B | ||
| Q3 24 | $1.6B | $18.0B | ||
| Q2 24 | $1.6B | $17.7B | ||
| Q1 24 | $1.7B | $16.1B |
负债/权益比CMPRPRX
| Q4 25 | 3.42× | 0.92× | ||
| Q3 25 | 3.59× | 0.93× | ||
| Q2 25 | 3.34× | 0.84× | ||
| Q1 25 | 3.41× | 0.78× | ||
| Q4 24 | 3.70× | 0.74× | ||
| Q3 24 | 2.91× | 0.74× | ||
| Q2 24 | 2.49× | 0.78× | ||
| Q1 24 | 2.19× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | — |
| 自由现金流率自由现金流/营收 | -15.1% | — |
| 资本支出强度资本支出/营收 | 5.8% | — |
| 现金转化率经营现金流/净利润 | -1.99× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $94.1M | — |
8季度趋势，按日历期对齐
经营现金流CMPRPRX
| Q4 25 | $-37.0M | $827.1M | ||
| Q3 25 | $-6.9M | $702.6M | ||
| Q2 25 | $21.8M | $364.0M | ||
| Q1 25 | $186.9M | $596.1M | ||
| Q4 24 | $-4.1M | $742.5M | ||
| Q3 24 | $-12.7M | $703.6M | ||
| Q2 24 | $-6.8M | $658.2M | ||
| Q1 24 | $86.2M | $664.6M |
自由现金流CMPRPRX
| Q4 25 | $-59.8M | — | ||
| Q3 25 | $-22.8M | — | ||
| Q2 25 | $3.8M | — | ||
| Q1 25 | $172.9M | — | ||
| Q4 24 | $-25.9M | — | ||
| Q3 24 | $-33.6M | — | ||
| Q2 24 | $-21.5M | — | ||
| Q1 24 | $56.2M | — |
自由现金流率CMPRPRX
| Q4 25 | -15.1% | — | ||
| Q3 25 | -10.0% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 35.0% | — | ||
| Q4 24 | -8.4% | — | ||
| Q3 24 | -16.1% | — | ||
| Q2 24 | -10.6% | — | ||
| Q1 24 | 15.4% | — |
资本支出强度CMPRPRX
| Q4 25 | 5.8% | — | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 8.4% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 7.1% | — | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 7.2% | — | ||
| Q1 24 | 8.2% | — |
现金转化率CMPRPRX
| Q4 25 | -1.99× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMP
| Highway Deicing Salt | $210.8M | 53% |
| Consumer Industrial Salt | $120.7M | 30% |
| Plant Nutrition | $60.8M | 15% |
| Transferred Over Time | $2.8M | 1% |
| Other | $1.0M | 0% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
